Full-Time

Director – Medical Affairs

Confirmed live in the last 24 hours

4D Molecular Therapeutics

4D Molecular Therapeutics

201-500 employees

Develops gene therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$222k - $264kAnnually

Senior

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following 4D Molecular Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Advanced degree required (PharmD/PhD/OD/MD) or equivalent degree with relevant therapeutic specialty in the pharmaceutical industry, community, academic or hospital environment required.
  • 5+ years of medical affairs experience in the pharmaceutical industry, academia, or equivalent for those holding an advanced degree such as PharmD/OD,etc.
  • Extensive knowledge of clinical trial methodology, regulatory and compliance requirements governing clinical trials, and experience in development of clinical strategy and the design of study protocols.
  • Must possess excellent oral and written English communication skills.
  • Ability to exercise judgment and address complex problems and create solutions across multiple projects.
Responsibilities
  • Adhere to medical strategy for entry into new indications and across indications ensuring this fits within the overall company strategy and maintaining cross functional alignment
  • Deliver on critical identified milestones
  • Provide input for cross functional partners including clinical development and commercial to ensure that there is a strong medical voice represented
  • Demonstrate strategic thinking to translate medical/clinical insights of treatment paradigms into growth opportunities, while driving competitive advantage
  • Act as scientific reviewer, contribute to company sponsored medical affairs research programs and external research, and lead the creation of a robust scientific education plan for healthcare professionals and other stakeholders as well as internal for global medical training, field medical leadership across all regions and HEOR
  • Build external relationship networks for existing and new indications to help drive trial enrollment, launch prep, and gain advice
  • Provide key strategic input into publication planning and review, medical backgrounders, FAQ and standard responses, internal training approach, and data dissemination.
  • Execute on full thought leader engagement strategic approach and ensuing plan and provide insight to the cross functional medical engagement plans
  • Deliver high quality educational presentations internally and externally, as required
  • Ensure a comprehensive and synergistic approach by collaborating across Medical Affairs, Regions, and other functions including Commercial and Development
  • Operate in a fully compliant manner in all internal and external interactions
  • Other duties as assigned, nothing in this job description restricts management’s right to assign or reassign duties and responsibilities to this job at any time
Desired Qualifications
  • Pre-launch preparation and launch experience strongly preferred
  • Retina experience required, candidates with existing relationships within the retina community strongly preferred
  • Global medical affairs experience a plus
4D Molecular Therapeutics

4D Molecular Therapeutics

View

4D Molecular Therapeutics develops gene therapies to treat serious genetic diseases by delivering specific genetic material to patients' cells using adeno-associated virus (AAV) vectors. Their focus is on patients with genetic disorders like cystic fibrosis, and they operate in the biopharmaceutical market, emphasizing research, clinical trials, and eventual commercialization of their therapies. The company differentiates itself through its proprietary technology, "Therapeutic Vector Evolution," which enhances the delivery of therapeutic genes. Their goal is to advance gene therapy solutions and ensure effective treatments are available to those in need.

Company Stage

IPO

Total Funding

$170.2M

Headquarters

Emeryville, California

Founded

2013

Growth & Insights
Headcount

6 month growth

4%

1 year growth

0%

2 year growth

5%
Simplify Jobs

Simplify's Take

What believers are saying

  • 4DMT secured a $962 million deal with Astellas for their vector technology.
  • Positive interim data from 4D-710 trials show promise for cystic fibrosis treatment.
  • Series C financing raised $75 million, boosting research and development capabilities.

What critics are saying

  • Public stock offering may dilute existing shareholders' equity, causing dissatisfaction.
  • Analysts cutting estimates suggest potential financial instability or unmet expectations.
  • Reliance on partnerships like Astellas poses risk if outcomes don't meet expectations.

What makes 4D Molecular Therapeutics unique

  • 4DMT uses proprietary Therapeutic Vector Evolution for advanced AAV vector creation.
  • Their focus is on gene therapies for serious genetic diseases like cystic fibrosis.
  • 4DMT's R100 vector technology efficiently targets retinal cells for eye disease treatment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours